Ubs Asset Management Americas Inc Mirum Pharmaceuticals, Inc. Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 161,490 shares of MIRM stock, worth $11.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
161,490
Previous 149,518
8.01%
Holding current value
$11.8 Million
Previous $6.74 Million
22.02%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding MIRM
# of Institutions
230Shares Held
56.1MCall Options Held
25.3KPut Options Held
98.9K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$496 Million18.24% of portfolio
-
Janus Henderson Group PLC London, X05.24MShares$382 Million0.14% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$236 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.76MShares$201 Million5.52% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$192 Million2.55% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $2.68B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...